Advanced or Refractory Leukemia
1 clinical trials · Condition
◉ Watch Advanced or Refractory Leukemia
| Record | Firm | Date |
|---|---|---|
| A Study of the Histone-deacetylase Inhibitor JNJ-26481585 in Patients With Advanced or Refractory Leukemia or Myelodysplastic Syndrome (NCT00676728) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2008-12-01 |
Track Advanced or Refractory Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.